How much dividend does Biosynex pay?
Over the past 12 months, Biosynex paid a dividend of 2 EUR . This corresponds to a dividend yield of about 158.23 %. For the coming 12 months, Biosynex is expected to pay a dividend of 0.06 EUR.
Biosynex Dividend 2025
Biosynex Dividend
0.06 EUR
Biosynex Dividend yield
158.23 %
Ticker
ALBIO.PA
ISIN
FR0011005933
WKN
A1H8G1
How much dividend does Biosynex 2025 pay?
According to the latest status from February 2025, Biosynex paid a total of 0.06 EUR per share in dividends within the last 12 months. With the current Biosynex price of 1.26 EUR, this corresponds to a dividend yield of 4.36 %. A dividend is paid times per year.
| 158.23 % Dividend Yield | = |
|
Historical Biosynex Dividends
A dividend is paid times per year. Last year, the payout months were and .
| Paydate | Dividend |
|---|---|
| 6/16/2022 | 2 |
| 6/26/2021 | 0.2 |
1
Biosynex dividend history and estimates FR0011005933 · A1H8G1
In 2024, Biosynex paid a dividend amounting to 0.06 EUR. Dividend means that Biosynex distributes a portion of its profits to its owners.
3 years
5 years
10 years
25 Years
Max
Dividend
Dividend (Estimate)
Details
Dividend
ⓘDividend Overview
The dividend per year chart for Biosynex provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.
Interpretation and Use
A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Biosynex’s potential for long-term investment and income generation through dividends.
Investment Strategy
Incorporate the dividend data in evaluating Biosynex's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.
Biosynex Dividend History
| Date | Biosynex Dividend |
|---|---|
| 2025e | 0.42 undefined |
| 2024e | 0.06 undefined |
| 2022 | 2 undefined |
| 2021 | 0.2 undefined |
| Dividend | Dividend (Estimate) | |
|---|---|---|
| 2006 | 0 EUR | 0 EUR |
| 2007 | 0 EUR | 0 EUR |
| 2008 | 0 EUR | 0 EUR |
| 2009 | 0 EUR | 0 EUR |
| 2010 | 0 EUR | 0 EUR |
| 2011 | 0 EUR | 0 EUR |
| 2012 | 0 EUR | 0 EUR |
| 2013 | 0 EUR | 0 EUR |
| 2014 | 0 EUR | 0 EUR |
| 2015 | 0 EUR | 0 EUR |
| 2016 | 0 EUR | 0 EUR |
| 2017 | 0 EUR | 0 EUR |
| 2018 | 0 EUR | 0 EUR |
| 2019 | 0 EUR | 0 EUR |
| 2020 | 0 EUR | 0 EUR |
| 2021 | 0.2 EUR | 0 EUR |
| 2022 | 2 EUR | 0 EUR |
| 2023 | 0 EUR | 0 EUR |
| 2024e | 0 EUR | 0.06 EUR |
| 2025e | 0 EUR | 0.42 EUR |
Is the Biosynex Dividend Safe?
Biosynex has been increasing the dividend for 2 years.
Over the past 10 years, Biosynex has increased it by an annual 0 %.
Over a five-year period, the distribution increased by 0%.
Analysts expect a Dividend Cut of 0% for the current fiscal year.
Biosynex dividend payout ratio FR0011005933 · A1H8G1
In 2024, Biosynex had a payout ratio of 66.86%. The payout ratio indicates the percentage of the company's profits that Biosynex distributes as dividends.
3 years
5 years
10 years
25 Years
Max
Payout ratio
Details
Payout ratio
ⓘWhat is Yearly Payout Ratio?
The yearly payout ratio for Biosynex represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.
How to Interpret the Data
A lower payout ratio for Biosynex could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.
Using the Data for Investments
Evaluate Biosynex's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.
Biosynex Payout Ratio History
| Date | Biosynex Payout ratio |
|---|---|
| 2025e | 88.43 % |
| 2024e | 66.86 % |
| 2023 | 66.86 % |
| 2022 | 131.58 % |
| 2021 | 2.14 % |
| 2020 | 66.86 % |
| 2019 | 66.86 % |
| 2018 | 66.86 % |
| 2017 | 66.86 % |
| 2016 | 66.86 % |
| 2015 | 66.86 % |
| 2014 | 66.86 % |
| 2013 | 66.86 % |
| 2012 | 66.86 % |
| 2011 | 66.86 % |
| 2010 | 66.86 % |
| 2009 | 66.86 % |
| 2008 | 66.86 % |
| 2007 | 66.86 % |
| 2006 | 66.86 % |
| Payout ratio | |
|---|---|
| 2006 | 66.86 % |
| 2007 | 66.86 % |
| 2008 | 66.86 % |
| 2009 | 66.86 % |
| 2010 | 66.86 % |
| 2011 | 66.86 % |
| 2012 | 66.86 % |
| 2013 | 66.86 % |
| 2014 | 66.86 % |
| 2015 | 66.86 % |
| 2016 | 66.86 % |
| 2017 | 66.86 % |
| 2018 | 66.86 % |
| 2019 | 66.86 % |
| 2020 | 66.86 % |
| 2021 | 2.14 % |
| 2022 | 131.58 % |
| 2023 | 66.86 % |
| 2024e | 66.86 % |
| 2025e | 88.43 % |
Dividend Details
Understanding Biosynex's Dividend Distributions
Biosynex’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.
Year-to-Year Comparison
Examining Biosynex's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.
Impact on Investments
Biosynex's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.
Interpreting Dividend Fluctuations
Changes in Biosynex’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.
Biosynex Aktienanalyse
What does Biosynex do?
The company Biosynex SA was founded in 2005 in Strasbourg, France. The company is a manufacturer and distributor of diagnostic test kits used for the rapid and accurate diagnosis of various infectious diseases and other health conditions. Biosynex SA has established itself as a leading player in the global health market in recent years. The business model of Biosynex SA includes the design, manufacture, and distribution of various medical diagnostic tests that are capable of quickly and efficiently detecting pathogens and other health conditions. The company offers a wide range of medical test kits that can be used for the diagnosis of HIV/AIDS, hepatitis C, syphilis, rapid pregnancy tests, menopause, bleeding during pregnancy, vitamin D deficiency, and many other health conditions. The main focus of Biosynex SA is on developing test kits that are easy to use and provide accurate and reliable results. With its technological know-how and collaboration with leading experts in the field of medical diagnostics, Biosynex SA has taken a leading position in the development and marketing of medical diagnostic test kits. By collaborating with doctors, hospitals, and clinics globally, Biosynex SA has successfully expanded its business. Biosynex SA has various business areas specifically focused on the marketing and distribution of medical diagnostic tests. The most well-known areas include gynecology, infectious diseases, and pediatrics. Biosynex SA also has a strong presence in the global market, including Asia, Europe, Africa, and America. One of the most well-known products of Biosynex SA is the HIV self-test called Autotest VIH®, which is available in many European countries and North America. The test kit is CE marked and approved by leading health authorities such as the WHO and the EU. The product is an important tool in reducing the spread of HIV infections and allowing people to make a confidential diagnosis of HIV/AIDS in a private setting. In the field of gynecology, Biosynex SA offers various products such as the Unistick® pregnancy test, Unistick® ovulation test, and Unistick® menopause test kit. These products enable women to easily and efficiently diagnose pregnancy, ovulation, and menopause. The test kits are easy to use, can be used at home, and provide results within minutes. In summary, Biosynex SA has earned its leading position in the global market due to its focus on innovative technology and high-quality product range. The company has made a significant contribution to improving healthcare worldwide with its expertise and commitment to diagnosing health conditions. Biosynex SA will continue to expand its business in the future to support even more people worldwide and further improve the quality of healthcare. Biosynex is one of the most popular companies on Eulerpool.com.Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Frequently Asked Questions about Biosynex stock
What is the dividend yield of Biosynex?
The current dividend yield of Biosynex is 158.23 %.
When does Biosynex pay dividends?
Biosynex pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Biosynex?
Biosynex paid dividends every year for the past 2 years.
What is the dividend of Biosynex?
For the upcoming 12 months, dividends amounting to 0.06 EUR are expected. This corresponds to a dividend yield of 4.36 %.
In which sector is Biosynex located?
Biosynex is assigned to the 'Health' sector.
Wann musste ich die Aktien von Biosynex kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Biosynex from 5/18/2022 amounting to 2 EUR, you needed to have the stock in your portfolio before the ex-date on 5/16/2022.
When did Biosynex pay the last dividend?
The last dividend was paid out on 5/18/2022.
What was the dividend of Biosynex in the year 2024?
In the year 2024, Biosynex distributed 0 EUR as dividends.
In which currency does Biosynex pay out the dividend?
The dividends of Biosynex are distributed in EUR.
Andere Kennzahlen von Biosynex
Our stock analysis for Biosynex Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Biosynex Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
